Valuation : Amgen Inc.

Market Cap 24TCr 20TCr 19TCr 18TCr 33TCr 22,74200Cr 33TCr 2,26300Cr 88TCr 11,37400Cr 89TCr 87TCr 37,93700Cr P/E 2026 *
27.9x
P/E 2027 * 24.9x
Enterprise Value 28TCr 24TCr 22TCr 21TCr 39TCr 26,70500Cr 39TCr 2,65700Cr 1,03900Cr 13,35600Cr 1,05000Cr 1,02700Cr 44,54800Cr EV / Sales 2026 *
7.18x
EV / Sales 2027 * 6.81x
Free-Float
99.77%
Yield 2026 *
2.29%
Yield 2027 * 2.42%
1 day-0.76%
1 week-1.21%
Current month+13.46%
1 month+16.21%
3 months+30.08%
6 months+15.20%
Current year+33.51%
1 week 429.38
Extreme 429.38
447.03
1 month 375.96
Extreme 375.96
447.03
Current year 318.21
Extreme 318.21
447.03
1 year 269.77
Extreme 269.77
447.03
3 years 248.38
Extreme 248.38
447.03
5 years 198.64
Extreme 198.64
447.03
10 years 133.64
Extreme 133.64
447.03
Manager TitleAgeSince
Chief Executive Officer 63 01/05/2012
Director of Finance/CFO 62 13/05/2010
Director of Finance/CFO 67 01/01/2020
Director TitleAgeSince
Chairman 63 01/01/2013
Director/Board Member 65 01/01/2012
Director/Board Member 71 01/01/2012
Date Insider Type Main position Quantity % Market Cap.
13/08/26 Fiscal year

Executive/Senior Manager

3,756 0.0007%
07/08/26 Free

Director

85 0.0000%
07/08/26 Free

Controller/Auditor

730 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-0.76%-1.21%+50.90%+70.45% 24TCr
-1.12%-8.14%+59.79%+112.43% 1,06000Cr
-1.57%-2.79%+50.59%+59.86% 65TCr
-1.81%-2.94%+23.90%+75.98% 46TCr
-1.17%-0.93%+40.43%+40.43% 37TCr
-2.00%-1.95%+23.06%+38.92% 30TCr
-0.98%+0.53%+2.04%+12.13% 26TCr
-3.18%-1.40%-15.87%-53.79% 21TCr
+0.52%+0.85%+29.73%+93.68% 18TCr
-0.99%-0.78%+12.44%-22.98% 16TCr
Average -1.31%-0.11%+27.70%+42.71% 38.92TCr
Weighted average by Cap. -1.35%-1.87%+37.48%+62.18%

Financials

2026 *2027 *
Net sales 3.89TCr 3.34TCr 3.13TCr 2.86TCr 5.39TCr 3,72000Cr 5.41TCr 37TCr 14TCr 1,86000Cr 15TCr 14TCr 6,20500Cr 4.02TCr 3.45TCr 3.23TCr 2.96TCr 5.57TCr 3,84000Cr 5.59TCr 38TCr 15TCr 1,92000Cr 15TCr 15TCr 6,40500Cr
Net income 859.76Cr 737.84Cr 690.8Cr 632.4Cr 1.19TCr 82TCr 1.2TCr 8.17TCr 3.19TCr 41TCr 3.23TCr 3.16TCr 1,37000Cr 939.37Cr 806.17Cr 754.76Cr 690.96Cr 1.3TCr 90TCr 1.31TCr 8.93TCr 3.49TCr 45TCr 3.53TCr 3.45TCr 1,49700Cr
Net Debt 4.15TCr 3.56TCr 3.33TCr 3.05TCr 5.75TCr 3,96300Cr 5.77TCr 39TCr 15TCr 1,98200Cr 16TCr 15TCr 6,61100Cr 3.58TCr 3.07TCr 2.88TCr 2.64TCr 4.96TCr 3,42300Cr 4.98TCr 34TCr 13TCr 1,71200Cr 13TCr 13TCr 5,70900Cr
Logo Amgen Inc.
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (95.8%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other 4.2%): primarily royalties. The United States account for 71.9% of net sales.
Employees
31,500
Date Price Change Volume
27/26/27 $436.99 -0.76% 17,51,736
26/26/26 $440.34 -0.43% 22,89,655
25/26/25 $442.24 -0.36% 21,01,323
24/26/24 $443.84 +1.03% 24,64,347
21/26/21 $439.33 +1.29% 21,14,751
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
34
Last Close Price
436.99USD
Average target price
388.48USD
Spread / Average Target
-11.10%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AMGN Stock